Hypolipidemic effects of chitosan and its derivatives in hyperlipidemic rats induced by a high-fat diet

  • Haitao Pan Guangdong Pharmaceutical University
  • Qingyun Yang Guangdong Pharmaceutical University
  • Guidong Huang Guangdong Pharmaceutical University
  • Chen Ding Guangdong Pharmaceutical University
  • Peiqiu Cao Guangdong Pharmaceutical University
  • Lanlan Huang Guangdong Pharmaceutical University
  • Tiancun Xiao Oxford University
  • Jiao Guo Guangdong Pharmaceutical University
  • Zhengquan Su Guangdong Pharmaceutical University
Keywords: Human nutrition, Metabolism, Molecular nutrition, Health claims

Abstract

Background: Hyperlipidemia (HLP) is the primary risk factor of cardiovascular disease (CVD). Various factors, including genetics, physical inactivity, and daily nutritional habits, affect the prevalence of HLP. Recently, it was revealed that dietary fibers, such as pectin, psyllium, and especially chitosan (CTS), may play important roles in hypolipidemic management. Thus, this study aims to determine the hypolipidemic effect and mechanism of CTS and its water-soluble derivatives, chitosan oligosaccharides (MN≤1,000 Da (COSI) and MN≤3,000 Da (COSIII)), in male hyperlipidemic rats induced by a high-fat diet (HFD).

Design: After the model creation, 120 Sprague-Dawley (SD) rats were equally assigned to 12 groups fed various diets as follows: the normal group with basic diet, an HFD group, an HFD group supplemented with three doses of CTS, COSI and COSIII groups, and an HFD group treated with simvastatin (7 mg/kg·d). After 6 weeks, body weight, fat/body ratio, and the relevant biomarkers of serum, liver, and feces were measured. Additionally, the histological analysis of liver and adipose tissue was performed, and the mRNA expressions of liver peroxisome proliferator-activated receptor-α (PPARα) and hepatic lipase (HL) were examined.

Results: Compared with HFD group, rats fed CTS, COSI, and COSIII showed a better ability to regulate their body weight, liver and cardiac indices, fat/body ratio, as well as serum, liver, and fecal lipids, and simultaneously to maintain the appropriate activity of liver and serum superoxide dismutase (SOD), alanine aminotransferase (ALT), aspartate aminotransferase (AST), as well as liver and fecal total bile acids (TBA). Simultaneously, there had been a higher mRNA expression of PPARα and HL in the treatment groups.

Conclusion: The obtained results suggested that these three function foods can effectively improve liver lipid metabolism by normalizing the expressions of PPARα and HL, and protect liver from the oxidized trauma by enhancing hepatic function, which could be potentially used to remedy hyperlipidemia.

Keywords: chitosan; chitosan oligosaccharides; hypolipidemic effect; high-fat diet; PPARα

(Published: 3 May 2016)

Citation: Food & Nutrition Research 2016, 60: 31137 - http://dx.doi.org/10.3402/fnr.v60.31137

Downloads

Download data is not yet available.
Published
2016-05-03
How to Cite
1.
Pan H, Yang Q, Huang G, Ding C, Cao P, Huang L, Xiao T, Guo J, Su Z. Hypolipidemic effects of chitosan and its derivatives in hyperlipidemic rats induced by a high-fat diet. fnr [Internet]. 2016May3 [cited 2019Apr.24];600. Available from: https://foodandnutritionresearch.net/index.php/fnr/article/view/1018
Section
Original Articles